rosiglitazone has been researched along with threonine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernández-Real, JM; Moreno-Navarrete, JM; Ortega, F; Ricart, W; Sabater, M; Sánchez-Garrido, MÁ; Tena-Sempere, M; Zorzano, A | 1 |
1 other study(ies) available for rosiglitazone and threonine
Article | Year |
---|---|
Phosphorylated S6K1 (Thr389) is a molecular adipose tissue marker of altered glucose tolerance.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Biomarkers; Blotting, Western; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Glucose Tolerance Test; Humans; Insulin Receptor Substrate Proteins; Male; Obesity, Morbid; Phosphorylation; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Ribosomal Protein S6 Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Rosiglitazone; Thiazolidinediones; Threonine | 2013 |